The U.S. COVID death toll has surpassed 800,000 as the world tackles a wave of the Omicron variant. Follow Newsweek's liveblog for all the latest.
The COVID death toll in the U.S. has topped 800,000 - the highest reported toll of any country in the world. Figures compiled by Johns Hopkins University yesterday confirmed the total number of virus-related deaths is about equal to the population of Minneapolis and Cleveland combined.
Meanwhile, in Europe, countries are grappling with how to react to the variant, with some opting for lockdowns and others introducing vaccine passports. In the U.K.,'We must remember all those we have lost' - Biden
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Britain Confirms World's First Known COVID-19 Omicron Variant DeathThe death comes amid speculation, absent sufficient evidence, that omicron might cause less severe disease than its predecessors.
Weiterlesen »
COVID-19 live updates: Omicron 'spreading at a rate we have not seen,' WHO saysLATEST: Cornell University is moving into a 'level red' alert after a 'significant' number of suspected omicron cases were detected among student samples.
Weiterlesen »
Omicron Variant Accounts for 3% of U.S. Covid-19 InfectionsCDC said the Omicron variant accounted for 3% of recent Covid-19 infections in the U.S. and more than 13% in the New York and New Jersey area
Weiterlesen »
Covid: Twelve possible Omicron cases prompts booster jab pushPlans to ramp up Covid booster jabs are outlined in Tynwald as more suspected Omicron cases emerge.
Weiterlesen »
Pfizer Says Its Covid-19 Pill Likely Works Against OmicronPfizer’s Covid-19 pill, which is up for FDA authorization, worked against Omicron in lab tests, the company said. A final analysis of a key study also confirmed the drug was 89% effective in high-risk adults.
Weiterlesen »
Pfizer confirms COVID pill's results, potency versus omicronPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. Separate laboratory testing shows the drug retains its potency against the omicron variant, the company announced, as many experts had predicted. Pfizer tested the antiviral drug against a man-made version of a key protein that omicron uses to reproduce itself.
Weiterlesen »